Maryland scholars on Monday alternately described President-elect Donald Trump’s pick to lead the U.S. Food and Drug Administration — Dr. Marty Makary, a Johns Hopkins researcher, surgeon and author — as a “courageous leader” and a “reasonable choice,” who nevertheless espouses some “worrisome” views.

President-elect Trump has picked Marty Makary, a Johns Hopkins’s surgeon who has espoused contrarian views about the COVID-19 pandemic, to lead the Federal Drug Administration. Makary is a surgical oncologist at Johns Hopkins University and an author.

The nominee, a surgeon at Johns Hopkins, has criticized the use of pesticides on food and the industry turning against “natural fat.”

Makary, a professor at Johns Hopkins University, is the latest in a string of Trump nominees who have declared the U.S. health system “broken” and in need of a shakeup.

Makary and Weldon, who have criticized the agencies they may soon run, were joined by Janette Nesheiwat, Trump’s pick to be surgeon general.

President-elect Donald Trump has selected Marty Makary, a Johns Hopkins surgeon who criticized the Biden administration’s Covid response, to lead the FDA. “FDA has lost the trust of Americans, and has lost sight of its primary goal as a regulator,” Trump said in a statement late Friday, adding Makary would “course-correct” the agency if confirmed.

A prolific medical research and author, Martin Makary criticized the FDA and CDC for their decision-making during the pandemic, although he describes himself as pro-vaccine.